Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients

Published:2012-11-19 Issue:4 Volume:4 Page:
ISSN:2038-8330
Container-title:Hematology Reports
language:
Short-container-title:Hematol Rep

Author:

Elias Marjanu Hikmah,Baba Abdul Aziz,Husin Azlan,Abdullah Abu Dzarr,Hassan Rosline,Sim Goh Ai,Wahid S. Fadilah Abdul,Ankathil Ravindran

Publisher

PAGEPress Publications

Subject

Hematology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study;BMC Research Notes;2024-04-20

2. Comparison of Clinicopathological Parameters, and Treatment Responses in Younger and Older Chronic Myeloid Leukaemia Patients Treated with Imatinib;NOVEMBER 2023;2023-11-13

3. Higher incidence of co-expression of BCR-ABL fusion transcripts in an Eastern Indian population;Egyptian Journal of Medical Human Genetics;2023-10-05

4. Novel pharmacological approach for the prevention of multidrug resistance (MDR) in a human leukemia cell line;Leukemia Research;2021-10

5. Potential treatment for chronic myeloid leukemia using microRNA: in silico comparison between plants and human microRNAs in targeting BCR-ABL1 gene;Egyptian Journal of Medical Human Genetics;2021-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP